Evidence map›Paper›PMID 24218609›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet.

Lauren E Buchanan, Emily B Dunkelberger, Huong Q Tran, Pin-Nan Cheng, Chi-Cheng Chiu, Ping Cao, Daniel P Raleigh, Juan J de Pablo, James S Nowick, Martin T Zanni

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed.

  1. Article
  2. Review
  3. Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. A structural model of toxic amyloid oligomers involved in type 2 diabetes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lauren E BuchananDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706-1396.
Emily B Dunkelberger
Huong Q Tran
Pin-Nan Cheng
Chi-Cheng Chiu
Ping Cao
Daniel P Raleigh
Juan J de Pablo
James S Nowick
Martin T Zanni

Funding

Structural mechanism of diabetic amyloid formationR01DK079895 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Martin T Zanni · 2008 to 2026
$7.7M
Biophysical Studies of Amyloid Formation by Polypeptide HormonesR01GM078114 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI RALEIGH, DANIEL P · 2008 to 2024
$5.1M
Mechanism of membrane-catalyzed amyloid formation in diabetesR01DK088184 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI DE PABLO, JUAN J, SKINNER, JAMES L · 2010 to 2011
$708k
NIDDK NIH HHS 1R01DK088184NIDDK NIH HHS DK79895NIDDK NIH HHS R01 DK079895NIDDK NIH HHS R01 DK088184NIGMS NIH HHS GM078114NIGMS NIH HHS R01 GM078114
6 · The paper itself

Abstract

Amyloid formation is implicated in more than 20 human diseases, yet the mechanism by which fibrils form is not well understood. We use 2D infrared spectroscopy and isotope labeling to monitor the kinetics of fibril formation by human islet amyloid polypeptide (hIAPP or amylin) that is associated with type 2 diabetes. We find that an oligomeric intermediate forms during the lag phase with parallel β-sheet structure in a region that is ultimately a partially disordered loop in the fibril. We confirm the presence of this intermediate, using a set of homologous macrocyclic peptides designed to recognize β-sheets. Mutations and molecular dynamics simulations indicate that the intermediate is on pathway. Disrupting the oligomeric β-sheet to form the partially disordered loop of the fibrils creates a free energy barrier that is the origin of the lag phase during aggregation. These results help rationalize a wide range of previous fragment and mutation studies including mutations in other species that prevent the formation of amyloid plaques.

Indexed as

AmyloidHumansIslet Amyloid PolypeptideIsotope LabelingMolecular Dynamics SimulationMutationProtein FoldingSpectrophotometry, InfraredAmyloidIslet Amyloid Polypeptideaggregation pathwayinhibitorsvibrational coupling

Identifiers

PMID24218609
PMCPMC3845187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.